Innovating targeting

Philogen is a Swiss-Italian biotechnology company, founded in 1996 and listed on the Italian Stock Exchange, with a mission to innovate the treatment of cancer and other serious conditions

Philogen Announces R&D Program Update

Fibromun shows activity in pretreated glioma and sarcoma patients; OncoFAP targets tumor lesions in cancer patients; a new product partnered with AbbVie entered...

Deposito del Verbale dell’Assemblea degli Azionisti (Price sensitive)

Philogen S.p.A. rende noto che il verbale dell’Assemblea degli Azionisti tenutasi il giorno 31 maggio 2021, in sede ordinaria e straordinaria, è a disposizione del...

Philogen to participate at the Goldman Sachs Eleventh Annual Biotech Symposium on September 7, 2021

Co-founder, CEO and CSO, Prof. Dario Neri has been invited to participate at the Eleventh Annual Biotech Symposium organised by Goldman Sachs on September 7, 2021. The...

Philogen to participate at the Morgan Stanley Virtual 19th Annual Global Healthcare Conference on September 9-15

Co-founder, CEO and CSO, Prof. Dario Neri has been invited to participate at the 19th Annual Global Healthcare Conference organised by Morgan Stanley on September 9-15,...

Comunicato Deliberazioni Assemblea / Press release Shareholders’ meeting decisions (Price sensitive)

L’Assemblea degli Azionisti di Philogen S.p.A. si è riunita in data 31/05/2021, in sede ordinaria e straordinaria.

Philogen Announces First Quarter 2021 Results

Philogen Announces First Quarter 2021 Results and Provides Update on Pipeline Progress

Philogen annuncia i risultati del primo trimestre 2021

Philogen annuncia i risultati del primo trimestre 2021 e fornisce un aggiornamento sui progressi della pipeline

The Board of Directors approves the net financial position for the first quarter of 2021

The Board of Directors approves the net financial position for the first quarter of 2021 in the amount of 104,668 thousand euro, and acknowledges the progress of the...

Il Consiglio di Amministrazione approva la posizione finanziaria netta relativa al primo trimestre 2021

Il Consiglio di Amministrazione approva la posizione finanziaria netta relativa al primo trimestre 2021, positiva pari a euro 104.668 migliaia, e prende atto dello...

Philogen Announces First Quarter 2021 Results and Provides Update on Pipeline Progress

  COMUNICATO STAMPA 05-12-2021   PRESS RELEASE - 2021-05-12

OUR SCIENCES

Learn about our strategy

PIPELINE

Learn more about our pipeline

WORK WITH US

Look at open positions